MARKET

BAX

BAX

Baxter Intl
NYSE

Real-time Quotes | Nasdaq Last Sale

86.28
+0.29
+0.34%
After Hours: 86.28 0 0.00% 18:26 01/21 EST
OPEN
86.65
PREV CLOSE
85.99
HIGH
86.82
LOW
85.51
VOLUME
2.35M
TURNOVER
--
52 WEEK HIGH
88.91
52 WEEK LOW
73.12
MARKET CAP
43.20B
P/E (TTM)
36.21
1D
5D
1M
3M
1Y
5Y
Inspirion Wealth Advisors, Llc Buys Janus Henderson Mortgage-Backed Securities ETF, Zscaler ...
Investment company Inspirion Wealth Advisors, Llc (Current Portfolio) buys Janus Henderson Mortgage-Backed Securities ETF, Zscaler Inc, Janus Henderson AAA CLO ETF, Hartford Total Return Bond ETF, WisdomTree U.S.
GuruFocus.com · 15h ago
Catalent (CTLT) to Advance Oral Drug Development With New Launch
Catalent's (CTLT) Xpress Pharmaceutics service offers a quicker alternative to the traditional clinical development model, lowering the time needed to complete clinical studies.
Zacks · 1d ago
Here's Why You Should Retain Chemed (CHE) Stock for Now
Investors are optimistic about Chemed (CHE), given impressive performance of the Roto-Rooter arm and solid growth in VITAS admissions.
Zacks · 2d ago
Abiomed (ABMD) Reports Positive Data Backing preCARDIA System
Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and increasing urine output in ADHF patients.
Zacks · 2d ago
Is ATI Physical Therapy, Inc. (ATIP) Outperforming Other Medical Stocks This Year?
Here is how ATI Physical Therapy, Inc. (ATIP) and Baxter International (BAX) have performed compared to their sector so far this year.
Zacks · 2d ago
PacBio (PACB) to Leverage Google's Deep Learning Technologies
PacBio's (PACB) research collaboration with Google will likely enhance its HiFi Sequencing technology to extract greater value from genomic data.
Zacks · 3d ago
Here's Why You Should Invest in Neogen (NEOG) Stock Now
Neogen's (NEOG) better-than-expected Q2 revenues and robust growth across Food Safety & Animal Safety businesses instill investor confidence.
Zacks · 3d ago
Best Momentum Stocks to Buy for January 18th
BAX, F, and EGO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 18, 2022
Zacks · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BAX. Analyze the recent business situations of Baxter Intl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

17.65%Strong Buy
58.82%Buy
23.53%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BAX stock price target is 97.80 with a high estimate of 110.00 and a low estimate of 88.00.
High110.00
Average97.80
Low88.00
Current 86.28
EPS
Actual
Estimate
0.260.520.771.03
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 1.50K
Institutional Holdings: 463.52M
% Owned: 92.58%
Shares Outstanding: 500.69M
TypeInstitutionsShares
Increased
356
29.70M
New
73
5.42M
Decreased
382
31.04M
Sold Out
87
4.59M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.93%
Healthcare Equipment & Supplies
-1.50%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jose Almeida
Chief Financial Officer/Executive Vice President
James Saccaro
Chief Operating Officer/Executive Vice President
Giuseppe Accogli
Senior Vice President/General Counsel
Sean Martin
Senior Vice President/Director of Human Resources
Jeanne Mason
Senior Vice President
James Borzi
Senior Vice President
Cristiano Franzi
Senior Vice President
Andrew Frye
Senior Vice President
Jacqueline Kunzler
Lead Director/Independent Director
Albert Stroucken
Director
Nancy Schlichting
Independent Director
Thomas Chen
Independent Director
John Forsyth
Independent Director
Peter Hellman
Independent Director
Michael Mahoney
Independent Director
Patricia Morrison
Independent Director
Stephen Oesterle
Independent Director
Cathy Smith
Independent Director
Thomas Stallkamp
Independent Director
Amy Wendell
Independent Director
David Wilkes
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.28
12/02/2021
07/12/2021
Dividend USD 0.28
09/02/2021
05/03/2021
Dividend USD 0.28
06/03/2021
02/16/2021
Dividend USD 0.245
02/25/2021
11/16/2020
Dividend USD 0.245
12/03/2020
07/14/2020
Dividend USD 0.245
08/28/2020
05/05/2020
Dividend USD 0.245
06/04/2020
02/18/2020
Dividend USD 0.22
02/27/2020
11/19/2019
Dividend USD 0.22
12/05/2019
07/16/2019
Dividend USD 0.22
08/29/2019
05/07/2019
Dividend USD 0.22
06/06/2019
02/19/2019
Dividend USD 0.19
02/28/2019
11/13/2018
Dividend USD 0.19
11/30/2018
07/17/2018
Dividend USD 0.19
08/30/2018
05/08/2018
Dividend USD 0.19
05/31/2018
02/20/2018
Dividend USD 0.16
03/01/2018
11/14/2017
Dividend USD 0.16
11/30/2017
07/18/2017
Dividend USD 0.16
08/30/2017
05/02/2017
Dividend USD 0.16
05/31/2017
02/21/2017
Dividend USD 0.13
03/01/2017
About BAX
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.

Webull offers kinds of Baxter International Inc stock information, including NYSE:BAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BAX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BAX stock methods without spending real money on the virtual paper trading platform.